David Toth
ABSTRACT
HIV, tuberculosis and histoplasmosis are infectious diseases that affect millions of people world-wide. We describe our efforts to find cures for these diseases using the technique of virtual screening to identify possible inhibitors for essential proteins in these organisms using one of the XSEDE supercomputers. We have completed the virtual screens and have found promising compounds for each disease. Cell culture experiments have supported the likelihood of a number of the compounds being effective for treating both histoplasmosis and tuberculosis.
- World Health Organization. 2012_epi_core_en.png. Global summary of the AIDS epidemic | 2011. http://www.who.int/hiv/data/2012_epi_core_en.png.Google Scholar
- World Health Organization. WHO | Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/en/index.html. Updated October, 2012.Google Scholar
- World Health Organization Report on Global Tuberculosis Control, 2009.Google Scholar
- Bullock, W. E., Interactions between human phagocytic cells and Histoplasma capsulatum. Arch Med Res, 1993. 24(3): p. 219--23.Google Scholar
- Eissenberg, L. G. and W. E. Goldman, Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis. Clin Microbiol Rev, 1991. 4(4): p. 411--21.Google Scholar
- Woods, J. P., Knocking on the right door and making a comfortable home: Histoplasma capsulatum intracellular pathogenesis. Curr Opin Microbiol, 2003. 6(4): p. 327--31.Google Scholar
- Deepe GS Jr. Histoplasma Capsulatum. In: Mandell G, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Elsevier; 2005:3012--26.Google Scholar
- Adams CP & Brantner VV (2006) Estimating the cost of new drug development: is it really 802 million dollars? (Translated from eng) Health Aff (Millwood) 25(2):420--428 (in eng).Google ScholarCross Ref
- Kola I & Landis J (2004) Can the pharmaceutical industry reduce attrition rates? (Translated from eng) Nat Rev Drug Discov 3(8):711--715 (in eng).Google ScholarCross Ref
- Payne DJ, Gwynn MN, Holmes DJ, & Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. (Translated from eng) Nat Rev Drug Discov 6(1):29--40 (in eng).Google ScholarCross Ref
- Collignon B, Schulz R, Smith JC, & Baudry J (2011) Task-parallel message passing interface implementation of Autodock4 for docking of very large databases of compounds using high-performance super-computers. (Translated from eng) Journal of Computational Chemistry 32(6):1202--1209 (in eng).Google ScholarCross Ref
- Ellingson SR & Baudry J (2011) High-throughput virtual molecular docking: Hadoop implementation of AutoDock4 on a private cloud. in Proceedings of the second international workshop on Emerging computational methods for the life sciences (ACM, San Jose, California, USA), pp 33--38. Google ScholarDigital Library
- O. Trott, A. J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, Journal of Computational Chemistry 31 (2010) 455--461.Google Scholar
- AutoDock Vina -- molecular docking and virtual screening program. http://vina.scripps.edu/manual.html#faq. Updated May, 2013.Google Scholar
- X. Zhang, S. Wong, and F. Lightstone, Message Passing Interface and Multithreading Hybrid for Parallel Molecular Docking of Large Databases on Petascale High Performance Computing Machines, Journal of Computational Chemistry, 34 (2013) 915--927.Google ScholarCross Ref
- Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G., ZINC: A Free Tool to Discover Chemistry for Biology. Journal of Chemical Information and Modeling 2012.Google Scholar
- Blacklight. http://www.psc.edu/index.php/computing-resources/blacklight. Updated 12/14/12.Google Scholar
- Texas Advanced Computing Center -- Ranger-User-Guide. http://www.tacc.utexas.edu/user-services/user-guides/ranger-user-guide. Updated 10/30/12.Google Scholar
Index Terms
- Attacking HIV, tuberculosis and histoplasmosis with XSEDE resources
Recommendations
Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action
Display Omitted Checking multiple and extensively drug resistant TB by targeting wild type and three mutant variants of DNA gyrase.After exhaustive screening of natural compounds, one compound namely, chebulinic acid (CA) was identified as active ...
Discovery of novel influenza inhibitors targeting the interaction of dsRNA with the NS1 protein by structure-based virtual screening
Influenza A Non-structural protein 1 (NS1A) RNA-Binding Domain (RBD) bound to a double-stranded RNA (dsRNA), which can inhibit the activation of antiviral pathway. The chemical compound binding sites at this pocket have abilities to block NS1 protein to ...
Structure-based drug design of novel M. tuberculosis InhA inhibitors based on fragment molecular orbital calculations
Abstract2-trans enoyl-acyl carrier protein reductase (InhA) is a promising target for developing novel chemotherapy agents for tuberculosis, and their inhibitory effects on InhA activity were widely investigated by the physicochemical ...
Graphical abstractOutline of proposing novel potent InhA inhibitors based on our ab initio molecular simulations based on protein-ligand docking and fragment molecular orbital methods.
Display Omitted
Highlights- Interactions between 2-trans enoyl-acyl carrier protein and its inhibitors were studied.
Comments